Combination of Circulating Tumor Cells with Serum Carcinoembryonic Antigen Enhances Clinical Prediction of Non-Small Cell Lung Cancer

Circulating tumor cells (CTCs) have emerged as a potential biomarker in the diagnosis, prognosis, treatment, and surveillance of lung cancer. However, CTC detection is not only costly, but its sensitivity is also low, thus limiting its usage and the collection of robust data regarding the significan...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xi, Wang, Xu, He, Hua, Liu, Ziling, Hu, Ji-Fan, Li, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440620/
https://www.ncbi.nlm.nih.gov/pubmed/25996878
http://dx.doi.org/10.1371/journal.pone.0126276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440620/
https://www.ncbi.nlm.nih.gov/pubmed/25996878
http://dx.doi.org/10.1371/journal.pone.0126276

Ejemplares similares